Eli Lilly's (LLY.N), opens new tab high profile weight-loss and diabetes drugs fell short of Wall Street sales estimates on Wednesday as supplies sat in warehouses, a 180-degree turn for the ...
Oct 27 (Reuters) - Eli Lilly (LLY.N), opens new tab expects to start selling ... Tirzepatide is the active ingredient in the U.S. firm's diabetes drug Mounjaro, and weight-loss drug Zepbound.
An injection pen of Zepbound, Eli Lilly’s weight-loss drug, is displayed in New York City ... for its injectable obesity drug Zepbound and diabetes medicine Mounjaro combined, raising concerns ...